Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zoetis

153.55
+9.146.33%
Pre-market: 151.20-2.3500-1.53%05:47 EDT
Volume:5.05M
Turnover:750.32M
Market Cap:68.76B
PE:28.07
High:154.29
Open:141.16
Low:139.70
Close:144.41
Loading ...

UTHR or ZTS: Which Is the Better Value Stock Right Now?

Zacks
·
08 Feb

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks
·
07 Feb

BMO Wins Top Honours at Fundata Gala, Recognized with Most ETF Awards

CNW Group
·
07 Feb

PAHC Stock Falls Despite Q2 Earnings & Revenue Beat, Margins Increase

Zacks
·
07 Feb

Zoetis (NYSE:ZTS) Has A Pretty Healthy Balance Sheet

Simply Wall St.
·
07 Feb

Phibro Animal Health Corp (PAHC) Q2 2025 Earnings Call Highlights: Strong Growth in Animal ...

GuruFocus.com
·
07 Feb

Zoetis Announces Q2 2025 Dividend Payment

TIPRANKS
·
07 Feb

Zoetis Declares Second Quarter 2025 Dividend

Business Wire
·
07 Feb

Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth

Zacks
·
06 Feb

Zoetis Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
06 Feb

Zoetis (ZTS) Ascends But Remains Behind Market: Some Facts to Note

Zacks
·
05 Feb

Librela U.S. label update ‘better than feared’ for Zoetis, says Morgan Stanley

TIPRANKS
·
05 Feb

Zoetis Adds Warnings to Label for Dog Pain Drug -- WSJ

Dow Jones
·
04 Feb

Zoetis Updates Label on Drug for Treatment of Canine Osteoarthritis

MT Newswires Live
·
04 Feb

Zoetis announces updated label for Librela

TIPRANKS
·
04 Feb

Zoetis Inc: Remains Confident in Safety and Effectiveness of Librela

THOMSON REUTERS
·
04 Feb

Zoetis Inc: Plans to Immediately Implement Updated Label Based on U.S. Post-Approval Experience With Librela

THOMSON REUTERS
·
04 Feb

Zoetis Announces U.S. Label Update for Librela® (Bedinvetmab Injection), a Treatment to Control Canine Osteoarthritis (Oa) Pain

THOMSON REUTERS
·
04 Feb

Zoetis Announces U.S. Label Update for Librela® (bedinvetmab injection), a Treatment to Control Canine Osteoarthritis (OA) Pain

Business Wire
·
04 Feb

Zoetis Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
01 Feb